Group 1 - Shanghai Xinruize Chemical Co., Ltd. has been established with a registered capital of 200,000 RMB [1] - The legal representative of the company is Ren Qinghua [1] - The business scope includes sales of specialized chemical products (excluding hazardous chemicals), chemical products sales (excluding licensed chemical products), new material technology promotion services, import and export of goods, technology import and export, and warehousing equipment leasing services [1]

Core Viewpoint - Titan Technology (688133) has seen a stock price increase of 8.73% this week, closing at 27.4 yuan, with a total market capitalization of 4.506 billion yuan [1] Company Announcement Summary - Titan Technology plans to acquire 100% equity of Apollo Scientific Ltd. (ASL) for approximately 55.85 million yuan to expand its overseas sales channels [1] - The acquisition involves a payment of 5,756,429 GBP, which is about 55.85 million yuan, and is not classified as a related party transaction or a major asset restructuring [1] - ASL reported a revenue of 87.09 million yuan and a net loss of 5.5 million yuan for the year 2024 [1] - The transaction is subject to approval from relevant national and local authorities and will be included in the company's consolidated financial statements upon completion [1] - The acquisition is expected to enhance the company's core competitiveness and diversify its product line [1]

Core Viewpoint - Shanghai Titan Technology Co., Ltd. plans to acquire 100% equity of Apollo Scientific Ltd. from Central Glass Japan for £5,756,429, aiming to enhance its international presence and core competitiveness [1][2][3]. Group 1: Investment Overview - The company intends to use its own or self-raised funds for the acquisition, which is not classified as a related party transaction or a major asset restructuring [1][4]. - The transaction is part of the company's strategic plan to expand overseas sales channels and accelerate internationalization [2][3]. Group 2: Transaction Details - The acquisition will result in Apollo Scientific Ltd. being included in the company's consolidated financial statements as a subsidiary [3]. - The transaction is subject to approval from relevant national and local authorities, and the company has authorized its management to handle the necessary procedures [4][5]. Group 3: Target Company Information - Apollo Scientific Ltd. is a private limited company registered in England, primarily engaged in the distribution and customized services of chemical products [6][7]. - The financial performance of Apollo Scientific Ltd. shows a revenue of £8.71 million in 2024 and a net loss of £0.55 million, with total assets of £11.55 million and total liabilities of £0.96 million [7][8]. Group 4: Strategic Benefits - The acquisition is expected to enhance the company's sales and warehousing systems, facilitating faster responses to overseas customer demands and expanding its global reach [3][8]. - The integration of Apollo Scientific Ltd. is anticipated to improve procurement channels and optimize costs, thereby enhancing profitability [3][8]. Group 5: Due Diligence and Valuation - The company has engaged professional institutions for legal and financial due diligence, ensuring compliance and risk assessment related to the transaction [8][9]. - The purchase price was determined based on the target company's net assets and potential business synergies, amounting to £5,756,429 (approximately ¥55.85 million) [8][9].